These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16424507)

  • 1. Resistance to HIV drugs in UK may be lower in some areas.
    Fox JM; Fidler S; Weber J
    BMJ; 2006 Jan; 332(7534):179-80. PubMed ID: 16424507
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of antiretroviral drug resistance.
    Wainberg MA; Zaharatos GJ; Brenner BG
    N Engl J Med; 2011 Aug; 365(7):637-46. PubMed ID: 21848464
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV drug resistance.
    Calmy A; Pascual F; Ford N
    N Engl J Med; 2004 Jun; 350(26):2720-1. PubMed ID: 15215494
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in antiretroviral therapy.
    Sobieszczyk ME; Jones J; Wilkin T; Hammer SM
    Top HIV Med; 2006; 14(1):36-62. PubMed ID: 16641526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New HIV drugs show promise in early studies.
    McCarthy M
    Lancet; 2002 Mar; 359(9308):767. PubMed ID: 11888592
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV drug resistance.
    Clavel F; Hance AJ
    N Engl J Med; 2004 Mar; 350(10):1023-35. PubMed ID: 14999114
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging resistance to nonnucleoside reverse transcriptase inhibitors: a warning and a challenge.
    Trachtenberg JD; Sande MA
    JAMA; 2002 Jul; 288(2):239-41. PubMed ID: 12095389
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance and other factors involved in therapy failure.
    Mallol S
    Antivir Ther; 2001; 6 Suppl 2():21-7. PubMed ID: 11678475
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT.
    Chappell BJ; Margot NA; Miller MD
    AIDS; 2007 Mar; 21(6):761-3. PubMed ID: 17413698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etravirine: new drug. Multidrug-resistant HIV: another option.
    Prescrire Int; 2009 Jun; 18(101):102-3. PubMed ID: 19637414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current insights into reverse transcriptase inhibitor-associated resistance.
    Wainberg MA; White AJ
    Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a role for etravirine in patients with Nonnucleoside reverse transcriptase inhibitor resistance?
    Scott C; Grover D; Nelson M
    AIDS; 2008 May; 22(8):989-90. PubMed ID: 18453859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
    MMW Fortschr Med; 2002 Aug; 144(33-34):60-1. PubMed ID: 12380157
    [No Abstract]   [Full Text] [Related]  

  • 15. A fossil record of zidovudine resistance in transmitted isolates of HIV-1.
    Kuritzkes DR
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13485-7. PubMed ID: 11717419
    [No Abstract]   [Full Text] [Related]  

  • 16. Revisiting the concept of a genetic barrier to resistance.
    Rusconi S
    J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
    [No Abstract]   [Full Text] [Related]  

  • 17. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections.
    Pauwels R
    Curr Opin Pharmacol; 2004 Oct; 4(5):437-46. PubMed ID: 15351347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral Resistance Mutations (revised April 2001).
    ;
    HIV Clin Trials; 2001; 2(4):346-55. PubMed ID: 11590539
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 5, 2001.
    Panel on Clinical Practices for Treatment of HIV Infection
    HIV Clin Trials; 2001; 2(3):227-306. PubMed ID: 11590532
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.